Neuropsicofarmacología - GIC 21/128
![Foto de Neuropsicofarmacología - GIC 21/128](/img/grupo.png)
![Foto de Hospital Vall d'Hebron](/img/noimage_org.png)
Hospital Vall d'Hebron
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital Vall d'Hebron (12)
2024
-
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study
Spanish Journal of Psychiatry and Mental Health
-
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
Seminars in Arthritis and Rheumatism, Vol. 65
2021
-
Pregnancy Control in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Part 1: Infertility, Ovarian Preservation and Preconception Assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER)
Reumatologia Clinica, Vol. 17, Núm. 2, pp. 61-66
-
Pregnancy control in Patients with Systemic Lupus Erythematosus/Antiphospholipid Syndrome. Part 3: Childbirth. Puerperium. Breastfeeding Contraception. Newborn
Reumatologia Clinica, Vol. 17, Núm. 4, pp. 183-186
-
Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 125-131
2020
-
Cannabis.
Manual de trastornos adictivos (J. Belarmino Bobes, M. Casas y M. Gutiérrez), pp. 559-567
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America
2016
-
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399
2012
-
Diagnosis and treatment of Lupus nephritis: Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish society of internal medicine (SEMI) and the Spanish society of nephrology (S.E.N.)
Nefrologia, Vol. 32, Núm. SUPPL. 1, pp. 1-45
-
Diagnosis and treatment of lupus nephritis
Revista Clinica Espanola
2010
-
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases
Clinical and Experimental Rheumatology, Vol. 28, Núm. 4, pp. 468-476